Skip to main content
Clinical Trials/CTRI/2018/09/015751
CTRI/2018/09/015751
Completed
未知

Intravenous dexamethasone as an adjunct to epidural labour analgesia with 0.125% ropivacaine in parturients.

A0 sites80 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
A
Enrollment
80
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 31, 2019
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
A

Eligibility Criteria

Inclusion Criteria

  • 1\.Parturients in established labour with cervical dilation \>3cm, with intact or absent membranes and having satisfactory uterine contractions with \>50% effacement.
  • 2\.Singleton pregnancy with vertex presentation at term,
  • 3\.Primigravidaor gravida 2 (previously normal delivered),
  • 4\.Age 18 years or above, weight less than 100kg, height 150 cm or more.

Exclusion Criteria

  • 1\.Patient refusal,
  • 2\.Any fetal anomalies,
  • 3\.History of coagulation disorders,
  • 4\.Any contraindications to epidural anaesthesia,
  • 5\.History of allergy to local anaesthetics,
  • 6\.Any obstetric complications (e.g., premature rupture of amniotic membranes,PIH),
  • 7\.Systemic and local sepsis,
  • 8\.Parturients having multiple pregnancies and premature labour,
  • 9\.History of peptic ulcer disease,
  • 10\.Known case of uncontrolled diabetes mellitus, and patient who had received dexamethasone in last 7 days for fetal lung maturity.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
To compare the pain relief during labour using a epidural local anaesthetic and an opioid versus epidural local anaesthetic and opioid along with intravenous steroid(dexamethasone)Health Condition 1: null- Age 18 yearsPrimigravidaSingle gestationCephalic presentation at â?¥ 36 wk of gestationIn early spontaneous labour (cervical dilation â?¤ 5 cm)Baseline pain score 30 (on a 0-100 VAS)
CTRI/2014/05/004596GMCH chandigarh80
Active, not recruiting
Phase 1
The effects of combined use of dexamethasone (corticosteroid) and dexmedetomidine (sedative) on a nerve block in patients undergoing surgery of the bones in the foot and ankle.Participants undergoing osseous surgery of the foot or ankle with a popliteal and saphenous nerve blocks as means of providing anagelsia with general anaesthesia will be investigated.MedDRA version: 20.0Level: LLTClassification code 10038286Term: Regional nerve blockSystem Organ Class: 100000004865Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
EUCTR2021-000429-28-DKZealand University Hospital, Department of Anaesthesiology120
Not yet recruiting
Not Applicable
Effect of combined use of two drugs dexamethasone and dexmedetomidine on duration of nerve blockHealth Condition 1: M958- Other specified acquired deformities of musculoskeletal system
CTRI/2020/11/029153SRI manakula vinayagar medical college hospital RESEARCH FUND
Completed
Not Applicable
Intratympanic injection with dexamethasone for sudden sensorineural hearing losssudden sensorineural hearing loss
JPRN-UMIN000005953The Jikei University School of Medicine25
Recruiting
Phase 4
Effectiveness of intravenous dexamethasone plus adductor canal block vs adductor canal block alone to prolong analgesia following total knee arthroplasty: A randomized controlled trialPatients undergoing elective unilateral TKAOA kneeTKAAdductor canal blockPain scoreMorphine consumption
TCTR20240428001Rayong Hospital64